MyD88 is an essential adaptor protein for most Toll-like receptors and IL-1 family receptors, and its genetic variants are associated with increased gastric cancer risk in humans, particularly in the context of Hp infection where bacterial recognition and inflammatory responses are critical. This evidence concerns the gene MYD88 and gastric cancer.